Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-11 4:30 pm Sale | 2025-12-08 | 13G | Phio Pharmaceuticals Corp. PHIO | Orca Capital AG | 538,707 4.900% | -161,714 (-23.09%) | Filing History |
| 2025-11-28 06:18 am Purchase | 2025-11-24 | 13G | Chijet Motor Company, Inc. CJET | Orca Capital AG | 437,285 9.900% | 437,285 (New Position) | Filing History |
| 2025-11-24 4:05 pm Purchase | 2025-11-20 | 13G | Phio Pharmaceuticals Corp. PHIO | Orca Capital AG | 700,421 6.500% | 291,160 (+71.14%) | Filing History |
| 2025-11-12 06:10 am Sale | 2025-11-07 | 13G | Phio Pharmaceuticals Corp. PHIO | Orca Capital AG | 409,261 4.900% | -390,739 (-48.84%) | Filing History |
| 2025-11-06 5:00 pm Purchase | 2025-11-03 | 13G | Phio Pharmaceuticals Corp. PHIO | Orca Capital AG | 800,000 9.800% | 519,358 (+185.06%) | Filing History |
| 2025-10-30 4:07 pm Sale | 2025-10-28 | 13G | Co-Diagnostics, Inc. CODX | Orca Capital AG | 2,248,182 3.700% | -3,752,953 (-62.54%) | Filing History |
| 2025-10-30 4:05 pm Purchase | 2025-10-28 | 13G | Co-Diagnostics, Inc. CODX | Orca Capital AG | 6,001,135 9.900% | 3,807,422 (+173.56%) | Filing History |
| 2025-09-19 4:05 pm Sale | 2025-09-18 | 13G | Co-Diagnostics, Inc. CODX | Orca Capital AG | 2,193,713 4.600% | -2,615,787 (-54.39%) | Filing History |
| 2025-09-18 4:05 pm Purchase | 2025-09-17 | 13G | Co-Diagnostics, Inc. CODX | Orca Capital AG | 4,809,500 9.900% | 4,809,500 (New Position) | Filing History |
| 2025-09-15 5:23 pm Sale | 2025-09-11 | 13G | Silexion Therapeutics Ltd. SLXN | Orca Capital AG | 109,432 4.900% | -21,818 (-16.62%) | Filing History |
| 2025-09-15 5:19 pm Purchase | 2025-09-11 | 13G | Silexion Therapeutics Ltd. SLXN | Orca Capital AG | 131,250 6.200% | 131,250 (New Position) | Filing History |
| 2025-09-09 4:24 pm Sale | 2025-09-04 | 13G | Purple Biotech Ltd. PPBT | Orca Capital AG | 306,394 4.900% | -298,606 (-49.36%) | Filing History |
| 2025-09-09 4:18 pm Purchase | 2025-09-04 | 13G | Purple Biotech Ltd. PPBT | Orca Capital AG | 605,000 9.900% | 605,000 (New Position) | Filing History |
| 2025-08-07 4:05 pm Sale | 2025-08-04 | 13G | Phio Pharmaceuticals Corp. PHIO | Orca Capital AG | 280,642 4.900% | -234,323 (-45.50%) | Filing History |
| 2025-07-23 4:05 pm Sale | 2025-07-22 | 13G | Rani Therapeutics Holdings, Inc. RANI | Orca Capital AG | 1,891,623 4.300% | -2,462,377 (-56.55%) | Filing History |
| 2025-07-17 4:59 pm Sale | 2025-07-15 | 13G | 60 Degrees Pharmaceuticals, Inc. SXTP | Orca Capital AG | 166,229 4.900% | -153,771 (-48.05%) | Filing History |
| 2025-07-17 4:57 pm Purchase | 2025-07-15 | 13G | 60 Degrees Pharmaceuticals, Inc. SXTP | Orca Capital AG | 320,000 9.900% | 320,000 (New Position) | Filing History |
| 2025-07-17 4:56 pm Purchase | 2025-07-14 | 13G | Rani Therapeutics Holdings, Inc. RANI | Orca Capital AG | 4,354,000 9.900% | 4,354,000 (New Position) | Filing History |
| 2025-06-11 4:07 pm Sale | 2025-06-06 | 13G | Venus Concept Inc. VERO | Orca Capital AG | 101,748 4.900% | -6,932 (-6.38%) | Filing History |
| 2025-06-11 4:05 pm Purchase | 2025-06-06 | 13G | Venus Concept Inc. VERO | Orca Capital AG | 108,680 5.900% | 108,680 (New Position) | Filing History |